Discrepancies Between Bayesian Vancomycin Models Can Affect Clinical Decisions in the Critically Ill.
Asad E PatanwalaDanijela SpremoMinji JeonYann ThomaJan Willem C AlffenaarSophie StockerPublished in: Critical care research and practice (2022)
values obtained from different pharmacokinetic models are often discordant, potentially contributing to differences in dosing decisions. This highlights the importance of selecting the optimal model.